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Association of parental pretransplant
psychosocial assessment with post-transplant
morbidity in pediatric heart transplant
recipients*
In patients with severe congenital or acquired
heart disease, OHT often provides the only
opportunity for survival. Post-transplant patient
survival continues to improve; the current one-yr
survival approaches 90% (1, 2). Previous studies
have identified black race and teenage age to be
independent risk factors for recurrent rejection
(3). A higher rejection-risk in black recipients
may be explained in part by immunologic factors
(4). However, socioeconomic, demographic and
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Abstract: Because parents assume the primary responsibility for pro-
viding ambulatory post-transplant care to pediatric patients, pretrans-
plant psychosocial evaluation in these recipients is usually focused on
parents rather than on patients themselves. We sought to determine
whether pretransplant parental psychosocial evaluation predicts post-
transplant medical outcome at current levels of psychosocial support.
We compared relative risk (RR) of rejection and hospitalizations (days
of all-cause hospitalization) following initial discharge in patients in
risk and control groups defined by their pretransplant parental psy-
chosocial evaluation. We also compared the two groups of patients for
the proportion of all outpatient trough cyclosporine A (CSA) or tac-
rolimus (FK) levels that were <50% of the target level (defined as the
mid-therapeutic range level). There were seven patients in the risk
group with a median age 0.25 yr (range 0.19–14.7 yr) and total follow
up 20.5 patient-yr. There were 21 patients in the control groups with a
median age of 2.1 yr (range 0.05–16.2 yr) and total follow up of
71.3 patient-yr. There was no significant difference between the groups
in rejection-risk or days of all-cause hospitalization early after trans-
plant (first six months). During the late period (after the first six
months), there were 11 rejection episodes in the risk group over
17.4 patient-yr and four rejection episodes in control group over
61.8 patient-yr of follow up. After adjustment for age and race, patients
in the risk category had a RR of 3.4 for developing a rejection episode
(p ¼ 0.06) and 3.1 for being inpatient (p < 0.001) during the late
period. Patients in the risk group were 2.9 times more likely to have
subtherapeutic trough levels (<50% target level) of calcineurin in-
hibitor (CSA or FK) during both early and late periods (p < 0.01 for
both periods) after adjustment for patient age and race. We conclude
that pretransplant parental psychosocial risk assessment is associated
with post-transplant morbidity in children after cardiac transplantation.
These patients may benefit from closer outpatient monitoring and a
higher level of psychosocial support.
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psychosocial factors that influence access to
healthcare resources as well as patient compli-
ance following transplant may also be important
determinants of patient outcome following trans-
plant. Indeed, psychosocial evaluations that
assess these factors appear to be useful in
identifying adult OHT recipients at higher risk
of adverse outcome (5–7). Psychosocial evalua-
tion of the recipient is routinely performed at
most centers prior to listing for OHT and is
considered a requirement by third party payers.
This evaluation identifies the challenges likely to
be faced by the patient, the family and the
transplant team following OHT thus allowing
focused intervention and additional psychosocial
support if necessary. Because parents assume
primary responsibility for providing ambulatory
post-transplant care to pediatric patients, pre-
transplant psychosocial evaluation for pediatric
recipients is usually focused on parents rather
than on patients themselves. Parental noncom-
pliance has been found to be a major issue
affecting outcome following organ transplanta-
tion in pediatric patients. Specifically, noncom-
pliance was demonstrated to comprise the
majority of problems in pediatric patients fol-
lowing liver transplantation, including dysfunc-
tion, hospitalization and graft loss (8). We have
observed that patients for whom no psychosocial
concerns are raised prior to transplant by either a
formal evaluation or by nurses caring for them
are less likely to have recurrent rejection and are
less likely to require hospitalization for medical
morbidity after their initial post-transplant dis-
charge. We hypothesized that children whose
parents are identified to be at-risk from a
psychosocial perspective will be at a higher risk
of recurrent rejection compared with controls
and will have a higher incidence-rate of days of
all-cause hospitalization following their initial
discharge following OHT. We also compared the
risk of low trough levels of CI between the two
patient groups classified according to their psy-
chosocial risk.
Patients and methods
This was a single-center retrospective cohort study con-
ducted after obtaining approval from institutional Human
Investigation Committee. The study included all 28 patients
<18 yr of age who underwent cardiac transplantation at
our institution since initiation of the transplant program in
1998 and who survived to discharge following OHT. Of
these, 15 patients were male (54%) and 13 were female
(46%). Thirteen patients were black (46%), 12 Caucasian
(43%), two Hispanic (7%) and one Asian (4%). The in-
dication for cardiac transplantation was un-repaired con-
genital heart disease in 14 (50%), and cardiomyopathy in
nine patients (32%). Five patients (18%) had previously
undergone a palliative procedure for congenital heart dis-
ease.
Psychosocial categories
A pediatric psychiatrist and a social worker with experience
in evaluating organ transplant candidates assigned each
patient into risk and control groups after reviewing pre-
transplant psychosocial characteristics obtained from the
pretransplant social work and psychiatry consultations from
patient medical records. A psychosocial risk stratification
inventory was supplied as a guideline for categorization (6).
This reference placed patients into one of three categories
based on their psychosocial risk. The data collected for this
study included parental age, education, employment, mar-
ital status, family size, means of transportation to the hos-
pital, support systems, religious beliefs regarding organ
transplantation, past history of protective service investi-
gations, substance abuse, domestic violence, noncompli-
ance, psychiatric illness and case referral to the ethics
committee. The assigners were blinded to patient identifiers,
race and medical outcome and classified patients based on
their concerns regarding the parent’s ability to care for a
medically complex patient. Due to a small sample size (n ¼
28), two (control and risk groups) rather than three psy-
chosocial risk categories were defined. The social worker
and psychiatrist agreed on the risk assignment in all 28
patients.
Outcome variables
We evaluated two primary outcome variables in this study:
(i) time to next rejection episode; and (ii) days of all-cause
hospitalization following the initial post-transplant dis-
charge. Because the risk of these outcomes is different early
(first few months) and late after transplant, we evaluated
these variables and their predictors separately for the first
six-month period (early period) and after the six months
(late period) following initial patient discharge. We defined
a rejection episode as any event that led to enhanced
immune suppression as previously defined in studies pub-
lished by the Pediatric Heart Transplant Study Group (3).
This enhanced immune suppression usually followed a
diagnosis of rejection by clinical and echocardiography
findings often with additional confirmation with an endo-
myocardial biopsy. On other occasions, rejection was
diagnosed by histopathologic findings following a routine
surveillance endomyocardial biopsy. We also compared the
two groups of patients for the proportion of all outpatient
trough CSA or FK levels that were <50% of the target
level (defined as the mid-therapeutic range level) that could
not be explained by an intercurrent illness (such as
gastroenteritis), drug interaction (recent medication
change) or a delayed blood draw.
Statistical analysis
The RR for rejection was analyzed using a marginal Cox
proportional hazards model for recurrent events which
allowed us to account for all rejection episodes in each
patient. Estimates of the RR (hazard ratio) for the risk
group were calculated for early and late time periods using
univariate as well as multivariable analyses, and 95% con-
fidence intervals constructed using robust sandwich variance
estimate. In the multivariable analyses, we adjusted for two
previously described risk factors – patient race (black vs.
non-black) and age (>10 vs. £ 10 yr). The RR (incidence
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rate ratio) of being inpatient (days of all-cause hospitaliza-
tion) for the risk group and the corresponding 95% con-
fidence intervals were calculated for both time periods using
Poisson regression models. Logistic regression was used to
compare the proportion of low CSA or FK levels between
the risk and control groups, adjusting for patient race and
age in a multivariable analysis as above.
Results
Of the 28 patients, seven patients were assigned
to the psychosocial risk group and 21 patients to
the control group. The median age at transplant
in the risk group was 0.25 yr (range 0.19–
14.7 yr). Their median follow up in this group
after initial discharge was 913 days (range
28–2878 days). This resulted in a total of
20.5 patient-yr of follow up. The median age at
transplant in the control group was 2.1 yr
(range 0.05–16.2 yr). Their median follow up
after OHT discharge was 1256 days (range
25–2484 days). This resulted in a total of
71.3 patient-yr of follow up in controls. There
was one death in the risk group and one patient
left our institution two yr following OHT. There
were no deaths or loss to follow up in controls.
Number of rejection episodes
During the early period (first 6 months), there
were three rejection episodes in the risk group
over 3.0 patient-yr of follow up and eight rejec-
tion episodes in control group over 8.9 patient-yr
of follow up. This resulted in incidence rates of
rejection of 1.0/patient-yr in the risk group and
0.9/patient-yr in the control group during this
period (p ¼ NS, incidence rate ratio ¼ 1.07).
During the late period (after the first 6 months),
there were 11 rejection episodes in the risk
group over 17.4 patient-yr of follow up and four
rejection episodes in control group over 61.8
patient-yr of follow up. This resulted in incidence
rates of rejection of 0.63/patient-yr in the risk
group and 0.05/patient-yr in the control group
during this period (p < 0.001, incidence rate
ratio ¼ 12.6).
Time to rejection
During the early period (first six months), black
race was the only significant predictor for rejec-
tion (p ¼ 0.04 in the univariate analysis and 0.06
in the multivariable analysis) (Table 1). The
psychosocial risk category was not a predictor
for rejection for this period. For the late period,
patient age (>10 yr), black race and psychoso-
cial risk group were all associated with rejection
in the univariate analysis. After adjustment for
patient age and race in a multivariable analysis,
patients in the risk category had a RR of 3.4 for
rejection compared with patients in the control
group (p ¼ 0.06).
All-cause hospitalization
The length of all-cause hospital stay during the
early period (six months following initial dis-
charge) was 20.1 days/patient-yr in the risk
group compared with 13.5 days/patient-yr in
controls (p ¼ 0.01) (Table 1). The length of all-
cause hospital stay during the late period (after
six months following initial discharge) was
5.9 days/patient-yr in the risk group compared
Table 1. Relative risk for time to rejection,
all-cause hospitalization and proportion
of outpatient trough calcineurin levels
<50% target
Univariate analysis Multivariable analysis
RR (95% CL) p-value RR (95% CL) p-value
Early period
Time to rejection
Risk group 1.16 (0.33–4.14) 0.82 0.74 (0.18–3.12) 0.68
Race (Black) 5.13 (1.06–24.39) 0.04 5.38 (0.93–31.25) 0.06
Age at transplant (>10 yr) 1.34 (0.40–4.46) 0.63 1.33 (0.35–5.09) 0.68
Hospital days
Risk group 1.49 (1.10–2.02) 0.01 1.29 (0.94–1.77) 0.12
Low CI levels
Risk group 2.80 (1.32–5.94) 0.007 2.93 (1.32–6.48) 0.008
Late period
Time to rejection
Risk group 9.10 (2.68–30.92) <0.001 3.40 (0.95–12.14) 0.06
Race (Black) 14.49 (1.88–90.91) 0.01 10.1 (2.55–40) 0.001
Age at transplant (>10 yr) 12.37 (2.63–58.18) 0.002 7.32 (1.13–47.28) 0.04
Hospital days
Risk group 1.56 (1.24–1.97) 0.002 3.14 (2.37–4.15) <0.001
Low CI levels
Risk group 3.23 (1.90–5.47) <0.001 2.92 (1.52–5.60) 0.001
RR, relative risk; CL, confidence limits; CI, calcineurin inhibitor.
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with 3.7 days/patient-yr in controls (p < 0.001)
(Table 1). After adjusting for patient age and
race in the multivariable analysis, there was no
significant difference between the risk and con-
trol groups for all-cause hospital stay during the
early period (RR for risk group 1.29, 95%
confidence intervals 0.94–1.77). However, during
the late period, patients in the risk group had a
longer all-cause hospital stay even after adjusting
for age and race (RR for risk group 3.14, 95%
confidence intervals 2.37–4.15).
CI levels
The risk group had a significantly greater
proportion of all CSA or FK levels that were
<50% of the target levels (defined as the mid-
therapeutic range level) during both (early and
late) time periods (Table 1). During the first
six months (early time period), 8.9% of all levels
in the risk group and 3.4% of all levels in the
control group were <50% of the target levels
(p ¼ 0.007). During the late period (after six
months), 14.8% of all levels in the risk group
and 5.1% of all levels in controls were <50% of
the target levels (p < 0.0001).
Discussion
Although parental psychosocial evaluation is
routinely performed during pretransplant assess-
ment of pediatric recipients, this study describes
for the first time, an association between parental
pretransplant psychosocial evaluation and post-
transplant recipient morbidity in pediatric heart
transplant recipients. After the first six months of
follow up, children of parents assigned to
psychosocial risk category were 3.4 times more
likely to have a rejection episode and 3.1 times
more likely to be inpatient compared with
controls. These findings suggest that the patients
in the psychosocial risk category may benefit
from closer outpatient monitoring and a higher
level of psychosocial support than practiced
currently.
Patients in the psychosocial risk category
were 2.9 times more likely to have low trough
CSA or FK levels during both early and late
follow-up periods. Despite more frequent sub-
therapeutic levels in the risk group, a higher
rejection rate was not noted in these patients
during the early period. This may be due to
frequent dose adjustments during the early
period in response to these low levels. Because
patients are monitored less frequently during
the late period, subtherapeutic levels may
persist for a long enough duration as to
increase the likelihood of acute rejection.
Although we did not assess compliance by
any other method, noncompliance could poten-
tially explain the finding of more frequent
subtherapeutic levels as well as higher rejec-
tion-risk in these patients. Non-compliance has
been reported to be as high as 33% in some
patient cohorts (9). In the current era of OHT,
immune suppression is lifelong and electronic
event monitoring has demonstrated that pa-
tients who had even minor variations in their
dosing schedule were at higher risk for late
acute rejection episodes (10). High variability in
trough CSA levels has been demonstrated to be
a marker for pediatric OHT recipients at
greater risk for recurrent rejection and hospi-
talization (11). Therefore, compliant adminis-
tration of immunosuppressants must be ensured
to decrease the incidence of transplant-related
complications.
Identifying at-risk children for transplant-
related morbidity based on caregivers psycho-
social evaluation is consistent with previous
studies that have correlated these evaluations in
adult recipients with their own medical out-
come (12). In adult OHT recipients, psychoso-
cial variables have been found to be associated
with compliance, number of rejection episodes
and the development of coronary lesions (7).
Socio-demographic factors including income,
geographic location and stability of the family
were shown to be significant predictors of graft
survival in renal transplant recipients (12).
Stratifying patients into categories depending
on the level of psychological symptoms, emo-
tional stability, and a history of noncompliance
to therapy has been useful to predict outcome
(13, 14). Previous studies have also found an
association between focused psychological
inventories that assess specific personality
parameters and poor clinical outcome (13,
15). In a pediatric cohort, a correlation
between pretransplant and post-transplant psy-
chological functioning was found in patients
and their families following OHT. However,
pretransplant psychosocial data was not corre-
lated with medical outcome parameters in that
study (16).
We found black race to be an important risk
factor for rejection both during early and late
periods following hospital discharge. This data
supports previously published reports of higher
morbidity and worse survival in blacks in both
children and adults (3, 4, 17, 18). Furthermore,
our study confirmed a previously published
finding that teenage age (age >10 yr in





The major limitation of this study is a small
sample size (number of patients). The duration of
follow up and inclusion of multiple events (all
rejections and all hospitalizations) for all patients
resulted in sufficient number of outcome events
for comparison of the two groups. Recognizing
the difficulty in adjusting for too many variables
with a small sample size, we chose to adjust for
only two previously established risk factors, race
and age and to treat each of these two variables
as dichotomous variables (black vs. non-black
rather than the actual race; >10 vs. £ 10 yr
rather than age as a continuous variable). The
dramatic change noted in the effect size (RR
change from 9.1 in univariate analysis to 3.4 after
adjustment for age and race) justifies performing
this analysis. It improves internal validity of the
proposed risk factor at the cost of making the
estimate less precise (with wide 95% confidence
intervals). The small sample size limited our
ability to: (i) analyze subgroups of risk category
patients (mild and major risk categories to
observe a gradient effect); (ii) adjust for addi-
tional covariates in a multivariable analysis; and
(iii) examine the interaction between race, age,
and risk group; these analyses were not attemp-
ted.
A second limitation of the study was that the
assignment of risk category in each patient was
not based on a quantifiable standardized psy-
chosocial scoring system. This added an element
of subjectivity to this classification. We adopted
this approach because the pretransplant consul-
tations did not collect data with equal details on
all psychosocial domains for all patients. This
prevented us from using a scoring system to
classify patients into risk categories. We acknow-
ledge the potential problem in directly extrapo-
lating this classification to other programs.
Although imprecise, this approach may be useful
because the discussion regarding psychosocial
risk in clinical settings during the pretransplant
work-up is based on a composite of psychosocial
information similar to that utilized in this study.
Furthermore, the findings of this study should
provide an impetus to further define and quantify
this risk factor (psychosocial risk) prospectively.
In summary, the results of this study suggest
an association between pretransplant parental
psychosocial risk assessment and post-transplant
medical outcome in children after cardiac trans-
plantation. The association demonstrated in this
study is hypothesis generating for a larger
prospective study to more clearly define this risk
factor using a standardized scoring system
applicable across institutions. Such a study may
also be helpful in identification of important
individual psychosocial variables that may affect
post-transplant outcome.
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